ZIVO Bioscience (ZIVO) News Today $17.01 -1.98 (-10.43%) As of 08/28/2025 03:14 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ZIVO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period ZIVO Bioscience (NASDAQ:ZIVO) versus Cortexyme (NASDAQ:CRTX) Head-To-Head ComparisonAugust 26 at 4:07 AM | americanbankingnews.comZIVO Bioscience (NASDAQ:ZIVO) Stock Price Crosses Above 50-Day Moving Average - Should You Sell?August 22, 2025 | marketbeat.comZIVO Bioscience (NASDAQ:ZIVO) Stock Price Passes Below 50 Day Moving Average - What's Next?June 25, 2025 | marketbeat.comZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in PoultryJune 20, 2025 | businesswire.comZIVO Bioscience (NASDAQ:ZIVO) Stock Price Passes Below 50 Day Moving Average - Here's What HappenedJune 17, 2025 | marketbeat.comZIVO Bioscience (NASDAQ:ZIVO) Share Price Crosses Above 50-Day Moving Average - Time to Sell?June 7, 2025 | marketbeat.comZIVO Bioscience (NASDAQ:ZIVO) Shares Cross Below 50-Day Moving Average - Should You Sell?May 30, 2025 | marketbeat.comZIVO Bioscience (NASDAQ:ZIVO) Share Price Crosses Above Fifty Day Moving Average - Here's What HappenedMay 17, 2025 | marketbeat.comUniversity of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in PoultryMay 7, 2025 | finance.yahoo.comUniversity of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in PoultryMay 6, 2025 | businesswire.comZIVO Bioscience (NASDAQ:ZIVO) Stock Crosses Below 200 Day Moving Average - Time to Sell?March 20, 2025 | marketbeat.comZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in PoultryFebruary 6, 2025 | businesswire.comZIVO Bioscience (NASDAQ:ZIVO) Stock Crosses Above Fifty Day Moving Average - What's Next?February 4, 2025 | marketbeat.comZivo Bioscience issues new shares, raises $1.5 millionJanuary 28, 2025 | msn.comZIVO Bioscience (NASDAQ:ZIVO) Shares Cross Above 50 Day Moving Average - What's Next?January 4, 2025 | marketbeat.comTuesday's Insider Activity: Top Buys and Sells in US Stocks RevealedJanuary 1, 2025 | investing.comZIVO Bioscience (NASDAQ:ZIVO) Share Price Passes Above 50-Day Moving Average - Here's WhyDecember 27, 2024 | marketbeat.comZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian InfluenzaDecember 20, 2024 | businesswire.comZIVO Bioscience (NASDAQ:ZIVO) Trading Up 3.6% - Should You Buy?December 7, 2024 | marketbeat.comZIVO Bioscience (NASDAQ:ZIVO) Shares Pass Above 50 Day Moving Average - Should You Sell?November 9, 2024 | marketbeat.comZIVO Bioscience (NASDAQ:ZIVO) Stock Crosses Above 50-Day Moving Average - Here's What HappenedOctober 8, 2024 | marketbeat.comZIVO Stock Earnings: Zivo Bioscience Reported Results for Q4 2023March 18, 2024 | investorplace.comHarmony Biosciences HoldingsMarch 4, 2024 | forbes.comRegencell Bioscience Holdings Ltd RGCFebruary 1, 2024 | morningstar.comMZIVO Bioscience Announces Uplisting to OTCQB MarketJanuary 29, 2024 | finance.yahoo.comIdeaya BiosciencesJanuary 18, 2024 | forbes.comDare Bioscience Inc DAREJanuary 14, 2024 | morningstar.comMZivo Bioscience (ZIVO) Price Target Increased by 500.00% to 36.72November 1, 2023 | msn.comZivo Bioscience Inc ZIVONovember 1, 2023 | morningstar.comMZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler ChickensOctober 30, 2023 | finance.yahoo.comZivo Bioscience Announces 1-for-6 Reverse Stock Split To Regain ComplianceOctober 26, 2023 | markets.businessinsider.comZivo Bioscience to effect reverse stock split to regain compliance with Nasdaq rulesOctober 26, 2023 | msn.comZIVO Bioscience to Present at the Dawson James Small Cap Growth ConferenceOctober 3, 2023 | finance.yahoo.comTrial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler ChickensSeptember 19, 2023 | finance.yahoo.comZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife ™ Algal Biomass Product Produced Over the Next 18 MonthsAugust 16, 2023 | businesswire.comZivo Bioscience: ZWorldwide to Buy All Zivolife Supply for First 18 Months of AgreementAugust 16, 2023 | marketwatch.comZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 MonthsAugust 16, 2023 | finance.yahoo.comZIVO Commences Sales of its Proprietary Algal Biomass as Human FoodJuly 26, 2023 | finance.yahoo.comZivo Bioscience Shares Jump Premarket After Dropping Plans for Securities OfferingJune 29, 2023 | marketwatch.comZIVO's GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientMay 30, 2023 | benzinga.comZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food IngredientMay 30, 2023 | finance.yahoo.comSK Bioscience Co Ltd (302440)May 10, 2023 | investing.comZivo Bioscience gets $1M loan from CEOApril 5, 2023 | msn.comZIVO Bioscience (Nasdaq:ZIVO) HeadlineTrading was temporarily halted for "ZIVO" at 10:04 AM with a stated reason of "LULD pause."...April 5, 2023 | marketbeat.comMaxim Group Keeps Their Buy Rating on Zivo Bioscience (ZIVO)March 17, 2023 | markets.businessinsider.comZivo Bio Shares Slide 23% on High Mortality Rate in Coccidiosis Treatment StudyFebruary 10, 2023 | marketwatch.comStocks to Watch: Blue Apron, Zivo Bioscience, Berkshire GreyFebruary 10, 2023 | marketwatch.comZIVO Reports Negative Results Of Study With Product Candidate For Coccidiosis Treatment In ChickensFebruary 10, 2023 | markets.businessinsider.comPressure BioSciences, One World team up to develop CBD sports performance drinksJanuary 29, 2023 | seekingalpha.comZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech BusinessOctober 25, 2022 | finance.yahoo.com Get ZIVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIVO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZIVO Media Mentions By Week ZIVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZIVO News Sentiment▼0.001.03▲Average Medical News Sentiment ZIVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZIVO Articles This Week▼20▲ZIVO Articles Average Week Get the Latest News and Ratings for ZIVO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ZIVO Bioscience and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CTNM News DBVT News GALT News VOR News JBIO News LXEO News PBYI News ALLO News IMMP News EDIT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZIVO) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZIVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZIVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access